COMMUNIQUÉS West-GlobeNewswire

Gala Pharmaceutical Files State License Application for Testing Facility
07/12/2018
IRVINE, Calif., Dec. 07, 2018 (GLOBE NEWSWIRE) -- Gala Pharmaceutical, Inc. (Ticker: GLPH), a robust and burgeoning Analytical testing company, today announced notable progress toward opening its doors and serving its [...]
Myriad Announces Important New Data for Its EndoPredict® Breast Cancer Test Will Be Presented at the 2018 San Antonio Breast Cancer Symposium
07/12/2018
EndoPredict is the Only Test to Answer Three Critical Questions: Risk of Breast Cancer Recurrence, Benefits of Chemotherapy and Who Can Forgo Extended Endocrine Therapy SALT LAKE CITY, Dec. 07, 2018 (GLOBE NEWSWIRE) -- [...]
Physician-Assisted Death and Lifeboat Ethics Pre-empt Oath of Hippocrates, States the Journal of American Physicians and Surgeons
07/12/2018
TUCSON, Ariz., Dec. 07, 2018 (GLOBE NEWSWIRE) -- Physician-assisted suicide (PAS) or physician-assisted death (PAD) are now receiving strong public support, writes Jeffrey Hall Dobken , M.D., M.P.H., in the winter issue [...]
iCAD Announces FDA Clearance of ProFound AI™ for Digital Breast Tomosynthesis
07/12/2018
High-performance, cancer detection technology built on artificial intelligence now available to healthcare facilities in the U.S. New U.S. clearance based on clinical results demonstrating unprecedented improvements in [...]
MediPets CBD Infused Dog Treats Win Prestigious Industry Award
07/12/2018
PotNetwork Holdings subsidiary wins 2018 Pet Industry Recognition Award in Dog Treats Functional Category MIAMI, Dec. 07, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Diamond CBD Inc., a wholly-owned subsidiary of [...]
DIAMEDICA ANNOUNCES PRICING OF INITIAL PUBLIC OFFERING AND NASDAQ LISTING
07/12/2018
MINNEAPOLIS, Dec. 07, 2018 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (“DiaMedica”) (NASDAQ:DMAC) (TSX‑V:DMA), a clinical stage biopharmaceutical company, announced today the pricing of its initial public offering [...]
T2 Biosystems Reports Granting of Inducement Awards
07/12/2018
LEXINGTON, Mass., Dec. 07, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, [...]
Heuro Canada First to Bring Revolutionary Neurological Health Technology to Canada
07/12/2018
Leader in traumatic brain injury management aims to change how Canadians address their neurological health SURREY, British Columbia, Dec. 07, 2018 (GLOBE NEWSWIRE) -- Heuro Canada Inc., a leading provider of innovative [...]
Rule 2.9 Announcement
07/12/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 7 December 2018 [...]
Sensorion Announces a Publication in Hearing Research on Kinetics of Prestin Blood Levels After Noise Trauma-Induced Hearing Loss
07/12/2018
Circulating levels of prestin may act as surrogate biomarker for hearing loss involving OHC loss MONTPELLIER, France, Dec. 07, 2018 (GLOBE NEWSWIRE) -- Sensorion (FR0012596468 – ALSEN) , a biotech company specializing [...]
Inspire Medical Systems, Inc. Announces Pricing of Offering of Common Stock
07/12/2018
MINNEAPOLIS, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive [...]
UPDATE: Momenta Pharmaceuticals Announces Pricing of Public Offering of Common Stock
07/12/2018
CAMBRIDGE, Mass., Dec. 06, 2018 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq: MNTA), a biotechnology company with a validated scientific platform focused on discovering and developing novel therapeutics to [...]
Viveve Announces Pricing of Public Offering of Shares of Common Stock
07/12/2018
ENGLEWOOD, Colo., Dec. 06, 2018 (GLOBE NEWSWIRE) -- Viveve Medical, Inc. (“Viveve”) (NASDAQ: VIVE), a medical technology company focused on women’s intimate health, today announced the pricing of an underwritten public [...]
Synthorx Announces Pricing of Initial Public Offering
07/12/2018
SAN DIEGO, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Synthorx, Inc. (Nasdaq: THOR), a biotechnology company using a first-of-its-kind Expanded Genetic Alphabet platform technology to discover and develop optimized biologics for [...]
Quotient Limited Announces Pricing of Underwritten Offering of Ordinary Shares
07/12/2018
JERSEY, Channel Islands, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT) (the Company), a commercial-stage diagnostics company, today announced the pricing of its previously announced underwritten [...]
New Clinical Data Further Validate SAVI SCOUT® Radar Localization System for Simpler, Positive Axillary Lymph Node Localization
07/12/2018
Poster Presentation at San Antonio Breast Cancer Symposium shows 100% successful wire- free localization with no migration throughout neoadjuvant chemotherapy treatment SAN ANTONIO, Dec. 06, 2018 (GLOBE NEWSWIRE) -- [...]
AEON Global Health Announces Adjournment of Annual Meeting of Shareholders until January 16, 2019
06/12/2018
Annual Meeting adjourned solely with respect to Proposal 4 – approval of an amendment to the Company’s Amended Certificate of Incorporation to continue to restrict certain transfers of its common stock in order to [...]
Canopy Rivers Enhances European Platform With Further Investment in Italy
06/12/2018
NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRES TORONTO, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Canopy Rivers Inc. (the “ Company ” or “ Canopy Rivers ”) (TSXV: RIV) is pleased to announce that it has [...]
Helix Biopharma Corp. Closes First Tranche of Private Placement
06/12/2018
RICHMOND HILL, Ontario, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX, FSE: “HBP”) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and [...]

Pages